
Canagliflozin tablets
Form: Tablets
Strength: 100 mg and 300 mg
Reference Brands: Invokana(US & EU)
Category: Diabetes
Canagliflozin is an oral sodium-glucose co-transporter 2 (SGLT2) inhibitor used for managing type 2 diabetes and reducing cardiovascular and renal risks. Approved by the FDA in 2013 under the brand Invokana (100 mg, 300 mg), it received EU approval via centralized procedure the same year. It may be used as monotherapy or in combination with other antidiabetic agents. Canagliflozin lowers blood glucose by promoting urinary glucose excretion. Periodic renal assessment is recommended. Through Pharmatradz.com, B2B pharmaceutical buyers can source Canagliflozin from globally audited manufacturers and exporters, ensuring compliance with USA FDA and EU EMA regulatory standards.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Premixed Insulins (70/30, 50/50) Injectable
Strength: U-100
Form: Vials, pens
Reference Brands: Humulin, Novolin(US); Mixtard, Humulin, Insuman(EU)
View Details Get EnquiryInsulin Lispro (Humalog) injectable
Strength: U-100, U-200
Form: Vials/pens
Reference Brands: Humalog, Admelog, Fiasp(US); Humalog, Fiasp(EU)
View Details Get EnquiryInsulin Aspart (Novolog) injectable
Strength: U-100, U-200
Form: Vials/pens
Reference Brands: Novolog, Fiasp(US &EU)
View Details Get EnquiryInsulin Glargine (Lantus) injectable
Strength: U-100, U-300
Form: Vials/pens
Reference Brands: Lantus, Basaglar, Toujeo(US); Lantus, Toujeo(EU)
View Details Get Enquiry